Skip to main content
PRFX
NASDAQ Life Sciences

PRF Technologies Announces 1-for-5 Reverse Stock Split to Maintain Nasdaq Listing

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
8
Price
$0.626
Mkt Cap
$2.662M
52W Low
$0.611
52W High
$5.47
Market data snapshot near publication time

summarizeSummary

PRF Technologies Ltd. announced a 1-for-5 reverse share split, effective February 6, 2026, to consolidate its ordinary shares and boost its per-share price, likely to regain compliance with Nasdaq's minimum bid price requirement.


check_boxKey Events

  • Reverse Share Split Announced

    The company will effect a 1-for-5 reverse share split, consolidating every five ordinary shares into one, effective February 6, 2026.

  • Impact on Outstanding Shares

    The number of issued and outstanding ordinary shares will be adjusted from 3,915,340 to 783,068 (subject to fractional share adjustments).

  • Fractional Share Treatment

    No fractional shares will be issued; all fractional shares will be rounded up to the nearest whole ordinary share.

  • Derivative Adjustments

    Proportionate adjustments will be made to the exercise price and number of shares for all outstanding warrants and options.


auto_awesomeAnalysis

PRF Technologies Ltd. is implementing a 1-for-5 reverse share split, a significant corporate action typically undertaken by companies to increase their per-share price and meet minimum listing requirements, such as Nasdaq's $1.00 bid price. This move comes as the company's stock is trading near its 52-week low of $0.611, indicating a struggle with market valuation despite recent strategic shifts including a name change, acquisitions, and new product initiatives. While the reverse split aims to prevent delisting, it does not alter the company's fundamental value and is often viewed negatively by investors as it can signal underlying financial distress or an inability to organically grow the share price. Investors should monitor the stock's performance post-split and the company's ability to sustain its price above the Nasdaq threshold.

At the time of this filing, PRFX was trading at $0.63 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.7M. The 52-week trading range was $0.61 to $5.47. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed PRFX - Latest Insights

PRFX
Apr 28, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
PRFX
Mar 27, 2026, 8:30 AM EDT
Filing Type: 6-K
Importance Score:
8
PRFX
Mar 27, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
PRFX
Mar 17, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
PRFX
Feb 18, 2026, 9:38 AM EST
Filing Type: 6-K
Importance Score:
8
PRFX
Feb 11, 2026, 8:54 AM EST
Filing Type: 6-K
Importance Score:
8
PRFX
Feb 03, 2026, 4:16 PM EST
Filing Type: 6-K
Importance Score:
8
PRFX
Jan 20, 2026, 9:07 AM EST
Filing Type: 6-K
Importance Score:
7
PRFX
Jan 15, 2026, 4:10 PM EST
Filing Type: 6-K
Importance Score:
8
PRFX
Jan 12, 2026, 9:10 AM EST
Filing Type: 6-K
Importance Score:
7